AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « reports »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
reporting < reports < reposition  Facettes :

List of bibliographic references indexed by reports

Number of relevant bibliographic references: 93.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000906 (2020) Dinesh Kumar Badyal [Inde] ; Rajiv Mahajan [Inde]Chloroquine: Can it be a Novel Drug for COVID-19.
000909 (2020) Guido Bendezu-Quispe [Pérou] ; Milton José Max Rodríguez-Zú Iga [Pérou] ; Yuani Miriam Roman [Pérou] ; Laura Melissa Mori-Llontop [Pérou] ; Ver Nica Peralta [Pérou] ; Fabián Fiestas [Pérou]
000917 (2020) Alexander C. Rokohl [Allemagne] ; Niklas Loreck [Allemagne] ; Philomena A. Wawer Matos [Allemagne] ; Joel M. Mor [Allemagne] ; Sarah Zwingelberg [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Claus Cursiefen [Allemagne] ; Ludwig M. Heindl [Allemagne][The role of ophthalmology in the COVID-19 pandemic].
000942 (2020) Nadin Melina Conto-Palomino [Pérou] ; María Luz Cabrera-Bueno [Pérou] ; Kenneth Grenis Vargas-Ponce [Pérou] ; Evelina Andrea Rond N-Abuhadba [Pérou] ; Noé Atamari-Anahui [Oman][Encephalitis associated with COVID-19 in a 13-year-old girl: A case report].
000995 (2020) Sayak Roy [Inde] ; MainakMukhopadhyay [Inde]Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint.
000A36 (2020) Yaerim Kim [Corée du Sud] ; Ohyun Kwon [Corée du Sud] ; Jin H. Paek [Corée du Sud] ; Woo Y. Park [Corée du Sud] ; Kyubok Jin [Corée du Sud] ; Miri Hyun [Corée du Sud] ; Ji Y. Lee [Corée du Sud] ; Hyun A. Kim [Corée du Sud] ; Seungyeup Han [Corée du Sud]Two distinct cases with COVID-19 in kidney transplant recipients.
000A50 (2020) M O Enzmann [États-Unis] ; M P Erickson [États-Unis] ; C J Grindeland [États-Unis] ; S M C. Lopez [États-Unis] ; S E Hoover [États-Unis] ; D D Leedahl [États-Unis]Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas.
000A96 (2020) Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine]The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
000B36 (2020) Felix Scholkmann [Suisse] ; Tanja Restin [Suisse] ; Marco Ferrari [Italie] ; Valentina Quaresima [Italie]The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review.
000B93 (2020) Feng He [République populaire de Chine] ; Qingqing Luo [République populaire de Chine] ; Ming Lei [République populaire de Chine] ; Lixin Fan [République populaire de Chine] ; Xinning Shao [République populaire de Chine] ; Kaiyuan Hu [République populaire de Chine] ; Shuguang Qin [République populaire de Chine] ; Na Yu [République populaire de Chine] ; Jie Cao [République populaire de Chine] ; Liuping Yang [République populaire de Chine]Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
000C03 (2020) Priyanka Pahan [États-Unis] ; Kalipada Pahan [États-Unis]Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
000C15 (2020) Alem Zekarias [Suède] ; Sarah Watson [Suède] ; Sara Hedfors Vidlin [Suède] ; Birgitta Grundmark [Suède]Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
000C52 (2020) Michele Costanzo [Italie] ; Maria Anna Rachele De Giglio [Italie] ; Giovanni Nicola Roviello [Italie]SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
000C55 (2020) Rajkumar Singh Kalra [Japon] ; Dhanendra Tomar [États-Unis] ; Avtar Singh Meena [Inde] ; Ramesh Kandimalla [Inde]SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
000C67 (2020) María Fernanda Zurita [Équateur] ; Adriana Iglesias Arreaga [Équateur] ; Adriana A. Luzuriaga Chavez [Équateur] ; Luis Zurita [Équateur]SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
000C92 (2020) Martin H. Stradner [Autriche] ; Christian Dejaco [Autriche, Italie] ; Jochen Zwerina [Autriche] ; Ruth D. Fritsch-Stork [Autriche]Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.
000D09 (2020) Eric A. Meyerowitz [États-Unis] ; Augustin G L. Vannier [États-Unis] ; Morgan G N. Friesen [États-Unis] ; Sara Schoenfeld [États-Unis] ; Jeffrey A. Gelfand [États-Unis] ; Michael V. Callahan [États-Unis] ; Arthur Y. Kim [États-Unis] ; Patrick M. Reeves [États-Unis] ; Mark C. Poznansky [États-Unis]Rethinking the role of hydroxychloroquine in the treatment of COVID-19.
000D19 (2020) Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred Hyoungju Kim [États-Unis]Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al.
000E01 (2020) Naina Mohamed Pakkir Maideen [Émirats arabes unis]Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?
000E05 (2020) Getu Zhaori ; Lu Lu ; Chunyan Liu ; Yongli GuoProgresses in clinical studies on antiviral therapies for COVID-19-Experience and lessons in design of clinical trials.
000E55 (2020) T Joseph Mattingly [États-Unis] ; Michael D. Hogue [États-Unis]Pharmacy's Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "reports" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "reports" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    reports
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021